HEC113995

Sunshine Lake Pharma Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	HEC113995
Sponsor	Sunshine Lake Pharma Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 (PHASE1)
The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HEC113995 CI brief — competitive landscape report
HEC113995 updates RSS · CI watch RSS
Sunshine Lake Pharma Co., Ltd. portfolio CI